Citigroup’s Enliven Therapeutics ELVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $240K | Sell |
|
|||||
|
2025
Q2 | $364K | Sell |
|
|||||
|
2025
Q1 | $607K | Sell |
|
|||||
|
2024
Q4 | $755K | Buy |
|
|||||
|
2024
Q3 | $738K | Buy |
|
|||||
|
2024
Q2 | $248K | Buy |
|
|||||
|
2024
Q1 | $138K | Buy |
|
|||||
|
2023
Q4 | $102K | Buy |
|
|||||
|
2023
Q3 | $45.7K | Sell |
|
|||||
|
2023
Q2 | $221K | Sell |
|
|||||
|
2023
Q1 | $247K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $4K | Sell |
|
|||||
|
2020
Q4 | $31K | Buy |
|
|||||
|
2020
Q3 | $5K | Sell |
|
|||||
|
2020
Q2 | $19K | Buy |
|